Secondary-immunodeficiency In Blood Cancer
We would like to speak with physicians ( hematologist-oncologists, immunologists, and infectious disease specialists) involved in the diagnosis, treatment, and ongoing management of patients with sid that is associated with chronic lymphocytic leukemia (cll), multiple myeloma (mm), or non-hodgkin’s lymphoma (nhl). We are aiming to carry out message testing to identify messages that are most compelling to physicians with respect to the diagnosis and treatment of secondary immune deficiency (sid) associated with hematological cancers. This is a 75-minutes paid phone consultation and a 10 minutes pre-task. If open to participating, please provide a brief answer to the screener below: 1. Do you see at least 10 patients per month with secondary immunodeficiency (sid) associated with chronic lymphocytic leukemia (cll), multiple myeloma, or non-hodgkin’s lymphoma (nhl)? Please note that we are only interested in your personal point of view and are not seeking confidential information. Referrals are highly appreciated
Mart |Marketing Director SPECT Europe
Sorry no real *****, I'm not a physician and not in any way involved in ***** CLL. There...
16 Hours LaterVICTOR |Zintro Expert
Thanks for asking for insights on this subject ***** confirm my availability for this consult...
16.5 Hours LaterAlessandro |Healthcare Manager
I am not a physician but I have experience as biologist/***** payer....
17.1 Hours Later